4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-046829
Chief Operating Officer gave up 359 shares (to pay taxes)
- Chief Operating Officer acquired 920 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williams Paul Christopher Chief Operating Officer | 2023-08-18 | Option exercise | +920 | 1,294 | D | ||
| Williams Paul Christopher Chief Operating Officer | 2023-08-18 | Shares withheld for taxes | −359 | $8.46 | $3,037 | 935 | D |
| Derivatives | |||||||
| Williams Paul Christopher Chief Operating Officer | 2023-08-18 | Option exercise · Restricted Stock Units | −920 | 13,193 | D | ||
Loading xslF345X05/doc4.xml…